ARTICLE https://harbor-dev.pubfactory.com/view/journals/jnccn/9/Suppl_4/article-pS-1.xml NCCN Biosimilars White Paper: Regulatory, Scientific, and Patient Safety Perspectives 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/9/article-p953.xml Have We Been Down This Road Before? 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/9/article-p955.xml What Level of Evidence: The Elusive Balance in Drug Development 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/9/article-p960.xml Kidney Cancer 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/9/article-p985.xml Role of Surgery for Locally Advanced and Metastatic Renal Cell Carcinoma 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/9/article-p997.xml Selecting Targeted Therapies for Patients With Renal Cell Carcinoma 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/9/article-p1011.xml Role of Immunotherapy for Renal Cell Cancer in 2011 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/9/article-p1020.xml Hodgkin Lymphoma 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/9/article-p1060.xml The Role of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Hodgkin Lymphoma 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/9/article-p1073.xml Evolution of Radiation Therapy Within the German Hodgkin Study Group Trials 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/9/article-pxvii.xml NCCN News 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/9/article-pxxxiii.xml Oncology Research Program 2019-01-02